T1	Participants 48 77	patients with type 2 diabetes
T2	Participants 211 240	Patients with type 2 diabetes
T3	Participants 580 609	patients with type 2 diabetes
T4	Participants 763 814	patients from primary-care practices and hospitals.
T5	Participants 672 748	5238 patients with type 2 diabetes who had evidence of macrovascular disease
